Manufacturing and marketing of chronic segment pharmaceutical products by Levin Formulations.
Annual revenue $344,990 Latest available
Total funding - Funding intelligence
Employees 20 Tracked headcount
Investors - Known backers
Products 2 Services tracked
Competitors - Brand Intelligence

About Levin Formulations

Levin Formulations is a company. The company has 20 employees as of April 06, 2024. Levin Formulations offers products and services including LEVITOR Series and GILFORMIN Variants.

  • Employees 20 as on 06 Apr, 2024
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Legal Name Levin Formulations Pvt. Ltd
  • Jurisdiction Hyderabad, Telangana, India
Operational Areas
Healthcare → Healthcare Products & Supplies Unlock Sub-Sector Unlock Segment
Healthcare → Pharmaceuticals & Therapeutics Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    $344.99 K (USD)
    5.18
    as on Mar 31, 2023
  • Net Profit
    -$35.24 K (USD)
    95.07
    as on Mar 31, 2023
  • EBITDA
    $738.99 (USD)
    -83.97
    as on Mar 31, 2023
  • Latest Funding Round
    Not available
  • Investors
    Not available
  • Employee Count
    20

    as on Apr 06, 2024

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Levin Formulations

Levin Formulations offers a comprehensive portfolio of products and services, including LEVITOR Series and GILFORMIN Variants.

Product name locked
Category locked
Primary

The LEVITOR series is manufactured for chronic conditions and marketed as part of pharmaceutical offerings

Product name locked
Category locked
Locked

GILFORMIN variants are produced for managing chronic health issues and distributed in the healthcare sector

Funding Insights of Levin Formulations

Premium access

Detailed funding history for Levin Formulations

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Levin Formulations

Investments
Premium access

Investment portfolio details for Levin Formulations

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Levin Formulations

Premium access

Detailed financials for Levin Formulations

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Levin Formulations Comparisons

Levin Formulations Primary company
Description
Manufacturing and marketing of chronic segment pharmaceutica...
Location
-
Founded Year
-
Annual Revenue
$344.99 K (USD)
Net Profit
-$35.24 K (USD)
EBITDA
$738.99 (USD)
Employees
20
As of 2024
Premium access

Peer comparison for Levin Formulations

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Levin Formulations

Premium access

Detailed competitors of Levin Formulations

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Levin Formulations

Premium access

Complete news archive for Levin Formulations

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Levin Formulations

As of Apr 06, 2024, the latest employee count at Levin Formulations is 20.

Annual revenue of Levin Formulations is $344.99K as on Mar 31, 2023.

Levin Formulations Pvt. Ltd. is recognized as a pharmaceuticals organization that concentrates on the manufacturing and marketing of products for chronic conditions. It was established in 2013 and converted to a private limited entity in 2019, with a vision centered on providing quality healthcare through essential and difficult-to-make medicines. Consistent growth is noted in the industry, emphasizing sustainability and a focus on humanitys health needs. Products such as LEVITOR and GILFORMIN are developed to address ongoing health challenges.

Levin Formulations offers LEVITOR Series and GILFORMIN Variants.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available